A multi-centre study whose leads include London-based researchers has found a new imaging solution that can more effectively detect the recurrence of prostate cancer and is linked to improved survival rates.

A multi-centre study whose leads include London-based researchers has found a new imaging solution that can more effectively detect the recurrence of prostate cancer and is linked to improved survival rates.

Led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph’s Health Care London and University Health Network (UHN), the study – carried out over seven years and published in the Journal of Nuclear Medicine – has found a novel imaging solution, called prostate-specific membrane antigen (PSMA) positron emission tomography (PET) scanni

See Full Page